ATLANTA, Nov. 18, 2008 (GLOBE NEWSWIRE) -- Holzer Holzer & Fistel, LLC is investigating possible violations of the federal securities laws by PharmaNet Development Group, Inc. ("PharmaNet" or the "Company") (Nasdaq:PDGI). The investigation focuses on allegations that the Company knew but failed to disclose that many of its contracts with bio-technology and pharmaceutical companies were likely to be cancelled, and therefore the Company lacked any reasonable basis for its positive statements about its future.
Shareholders who purchased PharmaNet common stock between November 1, 2007 and April 30, 2008 with questions concerning their legal rights are encouraged to contact Holzer Holzer & Fistel, LLC and its attorneys Michael I. Fistel Jr., Esq. or Marshall P. Dees, Esq. via email at mfistel@holzerlaw.com, or mdees@holzerlaw.com, or via toll-free telephone at (888) 508-6832.
Holzer Holzer & Fistel, LLC is an Atlanta, Georgia law firm that dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. More information about the firm is available through its website, www.holzerlaw.com and upon request from the firm. Holzer Holzer & Fistel, LLC has paid for the dissemination of this promotional communication, and Michael I. Fistel, Jr. is the attorney responsible for its content.